Table 1.

Clinical characteristics of INVEST and SPS3

Clinical characteristics	INVEST				SPS3
	Whites		Hispanics		Whites		Hispanics
	Controls N = 431	RHTN cases N = 226	Controls N = 394	RHTN cases N = 143	Controls N = 192	RHTN cases N = 71	Controls N = 239	RHTN cases N = 83
Age	70 ± 10	70 ± 9	66 ± 10	66 ± 10	64 ± 10	63 ± 9	63 ± 11	63 ± 11
Female	184 (43%)	114 (50%)	225 (57%)	87 (61%)	70 (36%)	18 (25%)	98 (41%)	37 (45%)
BMI, mean ± SD	29 ± 6	29 ± 6	28.5 ± 5	30 ± 5**	29 ± 6	31 ± 10	28 ± 4	30 ± 6##
SBP at RHTN classification	126 ± 9	141 ± 17*	124 ± 9	143 ± 18**	126 ± 9	138 ± 14#	122 ± 11	133 ± 14##
DBP at RHTN classification	73 ± 8	76 ± 11*	76 ± 7	84 ± 10**	71 ± 8	73 ± 9	67 ± 10	70 ± 10
Diabetes	64 (15%)	66 (29%)*	51 (13%)	25 (18%)	44 (23%)	25 (35%)#	71 (30%)	33 (40%)
Heart failure	27 (6%)	17 (8%)	6 (2%)	8 (6%)**	1 (1%)	2 (1.4%)	2 (0.9%)	1 (1.2%)
Myocardial infarction	170 (39%)	92 (41%)	35 (9%)	23 (16%)	6 (3%)	8 (11%)#	8 (3%)	2 (2%)
Peripheral vascular disease	40 (9%)	35 (16%)*	34 (9%)	23 (16%)**	4 (2%)	2 (3%)	0 (0%)	2 (2%)
Smoking	204 (47%)	113 (50%)	137 (35%)	44 (31%)	41 (21%)	21 (30%)	18 (8%)	3 (4%)

Continuous variables are expressed as means ± standard deviations (SD), categorical variables are expressed as frequency and percentages

BMI Body mass index, SBP systolic blood pressure, DBP diastolic blood pressure

^*p < 0.05 compared to controlled BP in INVEST Whites

^**p < 0.05 compared to controlled BP in INVEST Hispanics

^#p <0.05 compared to controlled BP in SPS3 Whites

^##p < 0.05 compared to controlled BP in SPS3 Hispanics